Close Menu

Metabolic Disease

News on research and diagnostics for metabolic disorders and metabolic diseases.

The FDA cleared the system, comprising a blood collection device and associated test to measure long-term glucose levels in patients with diabetes. 

The test combines a genetic risk analysis with behavioral and lifestyle assessments, and uses  Thermo Fisher Scientific's TaqMan OpenArray for genotyping.

While results are preliminary, the test could potentially be used in lieu of a liver biopsy.

The collaboration aims at automating the processing of up to 96 liquid biopsy samples at one time using Enable Bio's (ADAP) technology for immunoassays.

The test uses machine learning algorithms to assess predictive biomarkers and electronic health record information to identify progressive kidney disease.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.